Weight Loss Drugs Surge in Ads, Kaiser Doctor Explains Dos and Don'ts

Guidance on who qualifies, safe use, and what happens when patients stop Ozempic, Wegovy or Zepbound.

Jan. 29, 2026 at 3:55pm

With a surge in weight loss drug advertisements, a Kaiser Permanente doctor provides insights on who qualifies for these medications, how to use them safely, the limits of their effectiveness, and what patients can expect when they stop taking drugs like Ozempic, Wegovy, or Zepbound.

Why it matters

The increased marketing of weight loss drugs has led to growing public interest and questions about their safety and efficacy. As these medications become more widely prescribed, it's important for patients to understand the appropriate use and potential side effects.

The details

The doctor explains that these weight loss drugs, which include Ozempic, Wegovy, and Zepbound, are typically prescribed for individuals with a body mass index (BMI) over 30, or those with a BMI over 27 who also have weight-related health issues like high blood pressure or type 2 diabetes. The medications work by suppressing appetite and slowing gastric emptying. However, the doctor cautions that they are not a magic solution, and patients may regain weight after stopping the drugs.

  • The surge in weight loss drug advertisements has occurred over the past year.

The players

Kaiser Permanente

A large integrated health care organization that provides medical services to millions of patients in the United States.

Got photos? Submit your photos here. ›

What they’re saying

“These weight loss medications can be helpful for some patients, but they are not a cure-all and should be used with caution and under medical supervision.”

— Kaiser Permanente Doctor

The takeaway

While weight loss drugs can be a tool for some patients, they should be used responsibly and with an understanding of their limitations. Patients should work closely with their healthcare providers to determine if these medications are appropriate and to manage their use and potential side effects.